Lower Estimated Glucose Disposal Rate Linked to Higher First Myocardial Infarction Risk in Diabetes Read more about Lower Estimated Glucose Disposal Rate Linked to Higher First Myocardial Infarction Risk in Diabetes
Two Type 1 Diabetes-Specific Models Show Strong Agreement in Predicting 10-Year Cardiovascular Risk Read more about Two Type 1 Diabetes-Specific Models Show Strong Agreement in Predicting 10-Year Cardiovascular Risk
SCORE2-Diabetes Accurately Predicts Cardiovascular Risk in Type 1 Diabetes Read more about SCORE2-Diabetes Accurately Predicts Cardiovascular Risk in Type 1 Diabetes
Dapagliflozin Reduces Renal Glucose Uptake and Preserves Kidney Function in Type 2 Diabetes Tags SGLT-2 Inhibitor Read more about Dapagliflozin Reduces Renal Glucose Uptake and Preserves Kidney Function in Type 2 Diabetes
Absence of Standard Risk Factors Linked to Higher Cardiovascular Events in Acute Coronary Syndrome Tags Acute Coronary Syndrome Read more about Absence of Standard Risk Factors Linked to Higher Cardiovascular Events in Acute Coronary Syndrome
Paclitaxel-Based Endovascular Therapy Shows No Significant Benefit in Chronic Limb-Threatening Ischaemia Read more about Paclitaxel-Based Endovascular Therapy Shows No Significant Benefit in Chronic Limb-Threatening Ischaemia
Syndromic and Metabolic Cardiomyopathies Linked to Higher Cardiovascular Risk than Hypertrophic Cardiomyopathy Tags Myopathies Read more about Syndromic and Metabolic Cardiomyopathies Linked to Higher Cardiovascular Risk than Hypertrophic Cardiomyopathy
AI-Based Coronary Risk Assessment Enhances Preventive Therapy in Chest Pain Patients Read more about AI-Based Coronary Risk Assessment Enhances Preventive Therapy in Chest Pain Patients
cGMP Modulation Improves Hemodynamics in Heart Failure Patients Tags TPHT_others Read more about cGMP Modulation Improves Hemodynamics in Heart Failure Patients
SGLT2 Inhibitor Use After 80 Linked to Higher Discontinuation in Type 2 Diabetes Tags SGLT-2 Inhibitor Read more about SGLT2 Inhibitor Use After 80 Linked to Higher Discontinuation in Type 2 Diabetes